Cargando…
Effect of Cellular Location of Human Carboxylesterase 2 on CPT-11 Hydrolysis and Anticancer Activity
CPT-11 is an anticancer prodrug that is clinically used for the treatment of metastatic colorectal cancer. Hydrolysis of CPT-11 by human carboxylesterase 2 (CE2) generates SN-38, a topoisomerase I inhibitor that is the active anti-tumor agent. Expression of CE2 in cancer cells is under investigation...
Autores principales: | Hsieh, Yuan-Ting, Lin, Hsuan-Pei, Chen, Bing-Mae, Huang, Ping-Ting, Roffler, Steve R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624787/ https://www.ncbi.nlm.nih.gov/pubmed/26509550 http://dx.doi.org/10.1371/journal.pone.0141088 |
Ejemplares similares
-
Impediments to Enhancement of CPT-11 Anticancer Activity by E. coli Directed Beta-Glucuronidase Therapy
por: Hsieh, Yuan-Ting, et al.
Publicado: (2015) -
Structural insights into catalytical capability for CPT11 hydrolysis and substrate specificity of a novel marine microbial carboxylesterase, E93
por: Li, Yang, et al.
Publicado: (2023) -
CPT-11 converting carboxylesterase and topoisomerase I activities in tumour and normal colon and liver tissues
por: Guichard, S, et al.
Publicado: (1999) -
Involvement of Carboxylesterase in Hydrolysis of Propranolol Prodrug during Permeation across Rat Skin
por: Imai, Teruko, et al.
Publicado: (2013) -
Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11
por: Oosterhoff, D, et al.
Publicado: (2005)